Unknown

Dataset Information

0

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.


ABSTRACT: To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in a more severe cardiomyopathic phenotype than either did alone. Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation. The cardiomyopathic phenotype was exacerbated in MHC-PPAR mice fed a diet enriched in triglyceride containing long-chain fatty acid, an effect that was reversed by discontinuing the high-fat diet and absent in mice given a medium-chain triglyceride-enriched diet. Reactive oxygen intermediates were identified as candidate mediators of cardiomyopathic effects in MHC-PPAR mice. These results link dysregulation of the PPARalpha gene regulatory pathway to cardiac dysfunction in the diabetic and provide a rationale for serum lipid-lowering strategies in the treatment of diabetic cardiomyopathy.

SUBMITTER: Finck BN 

PROVIDER: S-EPMC298755 | biostudies-literature | 2003 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content.

Finck Brian N BN   Han Xianlin X   Courtois Michael M   Aimond Franck F   Nerbonne Jeanne M JM   Kovacs Attila A   Gross Richard W RW   Kelly Daniel P DP  

Proceedings of the National Academy of Sciences of the United States of America 20030127 3


To explore the role of peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated derangements in myocardial metabolism in the pathogenesis of diabetic cardiomyopathy, insulinopenic mice with PPARalpha deficiency (PPARalpha(-/-)) or cardiac-restricted overexpression [myosin heavy chain (MHC)-PPAR] were characterized. Whereas PPARalpha(-/-) mice were protected from the development of diabetes-induced cardiac hypertrophy, the combination of diabetes and the MHC-PPAR genotype resulted in  ...[more]

Similar Datasets

| S-EPMC3462191 | biostudies-literature
| S-EPMC6052396 | biostudies-literature
| S-EPMC6374395 | biostudies-literature
| S-EPMC6033867 | biostudies-literature
| S-EPMC7040199 | biostudies-literature
| S-EPMC9312289 | biostudies-literature
| S-EPMC10042943 | biostudies-literature
| S-EPMC4252176 | biostudies-literature
| S-EPMC8055007 | biostudies-literature
| S-EPMC4739422 | biostudies-literature